These two med-tech stocks are still fairly high risk, but they are approaching the profitability inflection point, and have long term tailwinds supporting the businesses.

I thought Diverger (ASX: DVR) would pay increasing dividends but the in company’s unaudited earnings presentation didn’t mention dividends.

ASX growth stocks Clinuvel Pharmaceuticals (ASX: CUV), Camplify (ASX: CHL) and Whispir (ASX: WSP) have all reported quarterly cashflow.

The CEO of Codan (ASX: CDA) suggests the business has pricing power, and a number of potential growth avenues.

Lasebond (ASX: LBL) uses laser beams and semi-molten droplets of coating at extremely high velocities to make things last longer.

Lovisa has experienced significant growth on the back of its first mover advantage in the cheap fast-fashion jewellery category. Let me take you through why I think Lovisa’s best days still lie ahead.

Australian Ethical Investment (ASX: AEF) has announced it will absorb Christian Super. However, the share price assumes very strong growth, on top of that.

This quick primer on Ansell may pique your interest in a stalwart stock trading at a relatively low multiple of earnings.

The founding family still owns over 30% of the shares of this dividend growth stock, which has grown its half year dividend by 1100% in the last 14 years.

Janison Education (ASX: JAN) has cash in the bank, growing revenue and improving gross profit margins, but it’s still making a loss.

Strong growth in subscription revenue has hampered profitability at RPM Global (ASX: RUL), but that won’t last forever…

Superloop has significant real world physical assets to sell, and is cashed up after a recent divestment. If the right things happen first, it could become a real opportunity.

Nanosonics (ASX: NAN) has a poor short term outlook but the very high short interest may create a tasty opportunity down the track.

Long term investing is the main game, but sometimes I like to think about shorter term trades, especially in a volatile market. Here are 4 for your watch list.

With the AGL Demerger abandoned, I am selling my shares at least until there is some other activist reason to hold them.

Brian Hartzer earned millions of dollars each year as CEO of Westpac but he has only spent $30,564.03 buying BeforePay (ASX: B4P) shares in May.

Watchlist stocks Codan (ASX: CDA), MSL Solutions (ASX: MSL), and Raiz Invest (ASX:RZI) have all updated the market in recent weeks.

Eroad (ASX: ERD) is a good business but management is too optimistic about underlying business conditions improving, in my opinion.

Dicker Data declared its first quarterly dividend for the year suggesting it will yield around 4.2% at current prices.

I use watchlists with target desired buy prices to help me take advantage of market volatility in a calm and measured way.